诊断检查延迟对I期非小细胞肺癌预后的影响
本研究基于NLST和IASLC两大数据库的回顾性数据,建立模型预测不同大小实性结节的治愈率,并评估90天、180天和365天诊断延迟对不同生长速度肿瘤预后的影响。结果显示,诊断延迟可显著降低肺癌特异性生存率和总生存率,且与既往I-ELCAP数据库结果一致。
要点
- 诊断延迟可降低I期非小细胞肺癌的治愈率,延迟180天时降幅为6.9%-8.3%。
- 肿瘤生长速度(VDT 60天为快速)越快,相同延迟时间下预后下降越明显。
- 20.0mm肿瘤伴60天VDT时,NLST数据库10年肺癌特异性生存率从83.4%降至延迟365天后的32.3%。
核心结论
- NLST和IASLC数据库证实了既往I-ELCAP数据库的估计,即诊断延迟可导致肺癌预后下降。
研究设计与样本
- 回顾性研究,利用NLST(2002年8月至2007年夏季)和IASLC(2011年1月至2019年12月)数据库,基于166例NLST和22590例IASLC非小细胞肺癌患者建立回归模型预测治愈率,采用Kaplan-Meier法计算生存率,并与既往I-ELCAP数据库结果比较。
诊断标准与关键数值
- 使用体积倍增时间(VDT)60、120、240天分别对应快速、中速和慢速肿瘤生长,评估90、180、365天延迟后的肿瘤直径增长及治愈率变化。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Diagnostic workup of small pulmonary nodules often requires follow-up CT scans to confirm nodule growth before invasive diagnostics or treatment. Purpose To confirm prior results from the International Early Lung Cancer Action Program (I-ELCAP) on quantifying decreases in lung cancer prognosis by using two large databases, the National Lung Screening Trial (NLST) and International Association for the Study of Lung Cancer (IASLC). Materials and Methods In this retrospective study, a model was developed to predict cure rates based on size of solid nodules using the NLST (August 2002 to summer 2007) and IASLC (January 2011 to December 2019) databases, focusing on stage I non-small cell lung cancer (NSCLC). Kaplan-Meier methods were used to calculate 10-year lung cancer-specific survival and 5-year overall survival rates for different tumor sizes. Tumor diameter increases after 90-, 180-, and 365-day delays were estimated using volume doubling times (VDTs) of 60, 120, and 240 days corresponding to fast, moderate, and slow tumor growth. Initial and delayed lung cancer cure rates were assessed across nine scenarios of time delays and tumor growth rates and compared with the previous results of the I-ELCAP database. Results Using regression models based on 166 NLST and 22 590 IASLC patients with NSCLC, 10-year lung cancer-specific survival and 5-year overall survival, respectively, for tumors 4.0-20.0 mm in diameter were estimated. For a 20.0-mm tumor with a 60-day VDT in the NLST database, the lung cancer-specific survival decreased from 83.4% to 76.5%, 66.8%, and 32.3% after 90, 180, and 365 days, respectively. The IASLC database showed similar decreases in 5-year overall survival, from 81.2% to 73.4%, 62.4%, and 23.3% after 90, 180, and 365 days, respectively. Comparison across NLST, IASLC, and I-ELCAP databases revealed minor variations in lung cancer cure rates between 79.9% and 83.4%, with reductions of 6.9%-8.3% after a 180-day delay with a 120-day VDT. Conclusion The NLST and IASLC databases confirmed prior estimates from the I-ELCAP database for the decrease in lung cancer prognosis due to diagnostic delays. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Park and Lee in this issue.
引用
- Yankelevitz DF, Yip R, Henschke CI, et al. Impact on Prognosis of Stage I Non-Small Cell Lung Cancer Secondary to Delays in Diagnostic Workup. Radiology. 2024. PMID: 39436291. doi:10.1148/radiol.240420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。